Trials / Completed
CompletedNCT02469545
Effect of Lactobacillus Plantarum 299v Supplementation on Major Depression Treatment
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Medical University of Bialystok · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to determine the influence of supplementation of probiotic Lactobacillus Plantarum 299V vs. placebo of probiotic during antidepressant monotherapy with SSRI (Selective Serotonin Reuptake Inhibitor) in patients with major depression.
Detailed description
For period of 8 weeks patient will receive probiotic Lactobacillus Plantarum 299V or its placebo as a supplementation of regular depression treatment with SSRI (Escitalopram or Sertraline). Psychometric and biochemical parameters will be monitored and evaluated. At day one, after 3 weeks (day 21) and after 8 weeks (day 56) of the study psychometric parameters will be measured such as Hamilton Depression Rating Scale, PSS-10 Scale, SCL-90 scale. At day one and after 8 weeks (day 56) of the study cognitive functions will be measured using: CVLT- California Verbal Learning Test, RFFT Ruff Figural Fluency Test, Stroop Test, Connecting Points Test (A and B), Attention and Perceptivity Test. At day one and after 8 weeks (day 56) of the study biochemical parameters will be measured such as: morning cortisol, pro and anti-inflammatory cytokines, tryptophan and its kynurenic pathway metabolites concentrations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lactobacillus Plantarum 299v | Administering antidepressant drug (SSRI - selective serotonin reuptake inhibitor) and probiotic - 2x1 caps. per day of Lactobacillus Plantarum 299V (10mld colony forming units in 1 caps.) for 8 weeks. |
| DRUG | Crystalline cellulose powder | Administering antidepressant drug (SSRI - selective serotonin reuptake inhibitor) and placebo of probiotic - 2x1 placebo caps. filled with micro-crystalline cellulose powder for 8 weeks. |
| DRUG | Escitalopram | 5-20mg daily |
| DRUG | Sertraline | 50-100mg daily |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2015-06-11
- Last updated
- 2018-09-07
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT02469545. Inclusion in this directory is not an endorsement.